Cetera Advisor Networks’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$472K Buy
2,054
+4
+0.2% +$903 ﹤0.01% 1969
2023
Q4
$451K Buy
2,050
+220
+12% +$50.7K ﹤0.01% 1966
2023
Q3
$413K Buy
1,830
+503
+38% +$116K ﹤0.01% 1917
2023
Q2
$293K Sell
1,327
-288
-18% -$63.8K ﹤0.01% 2103
2023
Q1
$362K Sell
1,615
-28
-2% -$6.9K ﹤0.01% 1924
2022
Q4
$457K Buy
1,643
+411
+33% +$104K ﹤0.01% 1703
2022
Q3
$258K Buy
+1,232
New +$275K ﹤0.01% 1703
2014
Q1
Sell
-5,504
Closed -$623K 812
2013
Q4
$623K Buy
5,504
+890
+19% +$80.3K 0.05% 360
2013
Q3
$367K Hold
4,614
0.03% 432
2013
Q2
$305K Buy
+4,614
New +$297K 0.03% 433

Other funds holding UTHR

Cetera Advisor Networks's UTHR Position: Q1 2024 in Review

Cetera Advisor Networks increased its United Therapeutics (UTHR) stake by 0.2% in Q1 2024, buying an estimated $903 and bringing the position to 2,054 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

Cetera Advisor Networks first reported a position in UTHR in Q2 2013 and has held it in 10 quarters since. The position peaked at $623K in Q4 2013. 526 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

  • Cetera Advisor Networks held 2,054 shares of United Therapeutics worth $472K as of Q1 2024.
  • Cetera Advisor Networks bought 4 United Therapeutics shares in Q1 2024, an estimated $903.
  • United Therapeutics made up ﹤0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #1969 holding.
  • Cetera Advisor Networks first reported a position in United Therapeutics in Q2 2013 and has held it in 10 quarters since.
  • Cetera Advisor Networks's United Therapeutics position peaked at $623K in Q4 2013.
  • 526 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.